Quantitative morphology using bronchial biopsies: FIGURE 1.
Authors:
- P. G. WoodruffPWP. G. Woodruff
- A. L. InnesAIA. L. Innes
Open Access
- 1 December 2006
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 15 (101) , 157-161
Abstract
Current drug treatments for chronic obstructive pulmonary disease (COPD) focus on managing symptoms of the disease and include short- and long-acting β2-agonists, anticholinergic agents (ipratroprium, tiotropium), methylxanthines (theophylline) and inhaled corticosteroids (ICS).Keywords
This publication has 16 references indexed in Scilit:
- Applying stereology to measure thickness of the basement membrane zone in bronchial biopsy specimensJournal of Allergy and Clinical Immunology, 2003
- Allergen challenge causes inflammation but not goblet cell degranulation in asthmatic subjectsJournal of Allergy and Clinical Immunology, 2001
- The optical rotatorJournal of Microscopy, 1997
- Morphometric model for pulmonary diffusing capacity I. Membrane diffusing capacityRespiration Physiology, 1993
- Workshop summary and guidelines: Investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseasesJournal of Allergy and Clinical Immunology, 1991
- The impact of recent stereological advances on quantitative studies of the nervous systemJournal of Neuroscience Methods, 1986
- Estimation of surface area from vertical sectionsJournal of Microscopy, 1986
- The unbiased estimation of number and sizes of arbitrary particles using the disectorJournal of Microscopy, 1984
- Determination of membrane thickness distribution from orthogonal interceptsJournal of Microscopy, 1979
- Distribution of Membrane Thickness Determined By Lineal AnalysisJournal of Microscopy, 1978